• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>DRS

DRS

  1. All
  2. 3rd Party
  3. Investing
  1. Onxeo: Validive® at the MASCC/ISOO International Symposium: Oral Presentation of Phase II Trial Results and Meeting with Its International Advisory Board

    Onxeo: Validive® at the MASCC/ISOO International Symposium: Oral Presentation of Phase II Trial Results and Meeting with Its International Advisory Board

  2. Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform

    Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform

  3. SciFluor Life Sciences Patented Compound SF0034 Highlighted in Research Published in The Journal of Neuroscience

    SciFluor Life Sciences Patented Compound SF0034 Highlighted in Research Published in The Journal of Neuroscience

  4. Research and Markets: North America Maritime Security Market Expected to Grow at a CAGR of 7.23% Over the Period 2014-2019, New Report Says

    Research and Markets: North America Maritime Security Market Expected to Grow at a CAGR of 7.23% Over the Period 2014-2019, New Report Says

  5. Klick Ideas Exchange to Showcase Emerging Technologies Being Adapted for Health Care

    Klick Ideas Exchange to Showcase Emerging Technologies Being Adapted for Health Care

  6. Leonard Hair Transplant Associates Introduces the Revolutionary ARTAS® Robotic System to Massachusetts

    Leonard Hair Transplant Associates Introduces the Revolutionary ARTAS® Robotic System to Massachusetts

  7. Roger Ibbotson, Benoit Mandelbrot, and George Cooper

    Our distinguished economics panel debates the value of current risk models.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.